Antony Currie has more than a decade of experience as a financial journalist, having worked with Euromoney since 1996, most recently as a US editor. He has worked on assignments in the major financial centres of Europe and the US and written stories on capital markets, global economies and the investment banking industry. He holds a bachelor's degree in German language and literature and a master's degree in politics and international relations from the University of Bristol. Follow Antony on Twitter @AntonyMCurrie
- Tel: +1 646 223 6094
- E-mail: firstname.lastname@example.org
As many boutique M&A firms as bulge-bracket players are working on the $160 bln pharma mega-merger. That’s a more even mix than the average this year. But the tax-driven deal’s roster includes Goldman, Morgan Stanley and JPMorgan, extending their league-table lead over rivals.
The $17 bln food giant is separating frozen fries from Chef Boyardee and Slim Jim. It’s the second big move for fast-acting boss Sean Connolly who joined in April and was followed into ConAgra by pushy investor Jana. Spinning rather than selling, however, demands more patience.
JPMorgan boss Jamie Dimon has pushed out or lost possible heirs. BofA and Citi have created chaos at the top. But the most valuable U.S. bank has positioned Tim Sloan to replace John Stumpf while also grooming other long-serving executives to step in. It’s a lesson in leadership.
- Wall Street gets early warning from Veritas LBO
- Apple and banks spoil for electronic-payment fight
- Islands sale emblematic of California water woes
- Fed feeds Goldman conspiracy-theory machine
- Square's down round offers cautionary unicorn tale
- BTG Pactual earnings flatter its performance
- Expedia finds back door to Airbnb's market